Auxilium (AUXL) Reports Publication of XIAFLEX IMPRESS Data; Most Co-Primary, Seconday Endpoints Met
Tweet Send to a Friend
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) announced that The Journal of Urology has electronically published the uncorrected proof of the Company's ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


